Identifying Independent Predictors of Mortality in COVID-19 Patients with Mucormycosis
| Autor: | Mohamed G Hamed, Abdelmonem Awad Hegazy, Ahmed Embaby, Shimaa Abdelmoneem, Amany Abd Al Badea, Ali Awad Ali Awad, Mohammad Walaa, Mai Ahmed Gobran, Omnia Awwad, Doaa AbdElmonem, Nahla A Zaitoun, Mona Ahmed Abdelmaksoud, Alhoussein Alsayed AbdelAal |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Biomedical and Pharmacology Journal. 15:1453-1467 |
| ISSN: | 2456-2610 0974-6242 |
| Popis: | Background: Coronavirus disease 2019 (COVID-19) may lead to immunosuppression, leaving patients vulnerable to secondary invasive fungal infection like mucormycosis. The present study aimed to determine whether there are any risk factors associated with mortality in mucormycosis among COVID-19 patients. Patients and Methods: Patients with COVID-19 diagnosed with mucormycosis who received treatment at University Hospitals were included in the study. Complete blood count (CBC), glycated hemoglobin (HBA1c), C-reactive protein (CRP), serum albumin level, creatinine, ferritin levels, lactate dehydrogenase (LDH), D-dimer and histopathological observations were performed for all participants’ specimens. Results: The number (N) of patients included in the study was 46. About 85 % (39/46) of patients had post-COVID-19 syndrome and the other 7 cases were in the active phase of the disease. CRP, serum ferritin, D-dimer, CRP/albumin ratio and CRP/absolute lymphocyte counts were statistically significant (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|